[CYCC] QoQ Quarter Result on 30-Sep-2016 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
14-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- 0.64%
YoY- -8.75%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
Revenue 0 0 277 205 222 139 424 -
PBT -2,455 -1,861 -3,249 -3,400 -3,591 -3,534 -3,872 -26.21%
Tax -268 -306 -409 -454 -626 -493 -498 -33.86%
NP -2,187 -1,555 -2,839 -2,946 -2,965 -3,041 -3,374 -25.12%
Tax Rate - - - - - - - -
Total Cost 2,187 1,555 3,116 3,151 3,187 3,180 3,798 -30.80%
Ratio Analysis
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
NP Margin 0.00 0.00 -1,024.91 -1,437.07 -1,335.59 -2,187.77 -795.75 -
Per Share
30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 31/12/15 CAGR
EPS -9.86 -7.28 -13.34 -16.96 -19.77 -20.51 -23.15 -43.42%
EPS Diluted -9.86 -7.28 -13.34 -16.96 -19.77 -20.51 -23.15 -43.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.